These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30664891)
1. Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies. Uttarkar S; Brembilla NC; Boehncke WH J Allergy Clin Immunol; 2019 Apr; 143(4):1302-1310. PubMed ID: 30664891 [TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis. Gober MD; Gaspari AA Curr Dir Autoimmun; 2008; 10():1-26. PubMed ID: 18460878 [TBL] [Abstract][Full Text] [Related]
3. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells. Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593 [TBL] [Abstract][Full Text] [Related]
4. Skin under Tnf influence: how regulatory T cells work against macrophages in psoriasis. Gatzka M J Pathol; 2017 Jan; 241(1):3-5. PubMed ID: 27747869 [TBL] [Abstract][Full Text] [Related]
5. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice. Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969 [TBL] [Abstract][Full Text] [Related]
6. Artesunate strongly modulates myeloid and regulatory T cells to prevent LPS-induced systemic inflammation. Mancuso RI; Azambuja JH; Olalla Saad ST Biomed Pharmacother; 2021 Nov; 143():112211. PubMed ID: 34649344 [TBL] [Abstract][Full Text] [Related]
7. Investigating the roles of regulatory T cells, mast cells and interleukin-9 in the control of skin inflammation by vitamin D. Gorman S; Geldenhuys S; Weeden CE; Grimbaldeston MA; Hart PH Arch Dermatol Res; 2018 Apr; 310(3):221-230. PubMed ID: 29392411 [TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes. Leite Dantas R; Masemann D; Schied T; Bergmeier V; Vogl T; Loser K; Brachvogel B; Varga G; Ludwig S; Wixler V J Pathol; 2016 Nov; 240(3):366-377. PubMed ID: 27555499 [TBL] [Abstract][Full Text] [Related]
9. Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor Cells. Alpdundar Bulut E; Bayyurt Kocabas B; Yazar V; Aykut G; Guler U; Salih B; Surucu Yilmaz N; Ayanoglu IC; Polat MM; Akcali KC; Gursel I; Gursel M J Immunol; 2020 Nov; 205(10):2707-2718. PubMed ID: 33028617 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice. Deng G; Chen W; Wang P; Zhan T; Zheng W; Gu Z; Wang X; Ji X; Sun Y Int Immunopharmacol; 2019 Sep; 74():105682. PubMed ID: 31203155 [TBL] [Abstract][Full Text] [Related]
11. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation. Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261 [TBL] [Abstract][Full Text] [Related]
12. Immune-modulation via IgD B-cell receptor suppresses allergic skin inflammation in experimental contact hypersensitivity models despite of a Th2-favoured humoral response. Nguyen TG Immunol Lett; 2018 Nov; 203():29-39. PubMed ID: 30218740 [TBL] [Abstract][Full Text] [Related]
13. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. Morimura S; Oka T; Sugaya M; Sato S J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687 [TBL] [Abstract][Full Text] [Related]
14. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis. Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906 [TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation. Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402 [TBL] [Abstract][Full Text] [Related]
19. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model. Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine. Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]